Clinical Trial
doi: 10.1136/jnnp.61.3.324-a.
Cholinesterase inhibition in Parkinson's disease
- PMID: 8795611
- PMCID: PMC486563
- DOI: 10.1136/jnnp.61.3.324-a
Item in Clipboard
Clinical Trial
Cholinesterase inhibition in Parkinson's disease
J Neurol Neurosurg Psychiatry.
1996 Sep.
No abstract available
Similar articles
-
Parkinson's disease dementia--a first step?N Engl J Med. 2004 Dec 9;351(24):2547-9. doi: 10.1056/NEJMe048305. N Engl J Med. 2004. PMID: 15590960 No abstract available.
-
[Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing].Lakartidningen. 2006 May 10-16;103(19):1537; discussion 1537-8. Lakartidningen. 2006. PMID: 16805251 Swedish. No abstract available.
-
Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.Front Neurol Neurosci. 2009;24:135-139. doi: 10.1159/000197892. Epub 2009 Jan 26. Front Neurol Neurosci. 2009. PMID: 19182471 Review.
-
Diffuse Lewy body disease: a common yet misdiagnosed dementia in which neuroleptics may be contraindicated.Tenn Med. 1998 Feb;91(2):58-60. Tenn Med. 1998. PMID: 9478123 Review. No abstract available.
-
Rivastigmine for dementia associated with Parkinson's disease.N Engl J Med. 2005 Mar 31;352(13):1387; author reply 1387. doi: 10.1056/NEJM200503313521325. N Engl J Med. 2005. PMID: 15800242 No abstract available.
Cited by
-
Benefit-risk considerations in the treatment of dementia with Lewy bodies.Drug Saf. 2002;25(7):511-23. doi: 10.2165/00002018-200225070-00005. Drug Saf. 2002. PMID: 12093309 Review.
-
Cholinesterase inhibitors for behavioral disturbance in dementia.Curr Psychiatry Rep. 2001 Jun;3(3):251-8. doi: 10.1007/s11920-001-0061-7. Curr Psychiatry Rep. 2001. PMID: 11353590 Review.
-
Molecular Assembly and Biosynthesis of Acetylcholinesterase in Brain and Muscle: the Roles of t-peptide, FHB Domain, and N-linked Glycosylation.Front Mol Neurosci. 2011 Oct 25;4:36. doi: 10.3389/fnmol.2011.00036. eCollection 2011. Front Mol Neurosci. 2011. PMID: 22046147 Free PMC article.
-
Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?CNS Spectr. 2008 Mar;13(3 Suppl 4):26-33. doi: 10.1017/s1092852900017296. CNS Spectr. 2008. PMID: 18323764 Free PMC article. Review.
-
Economic evaluation of rivastigmine in patients with Parkinson's disease dementia.Pharmacoeconomics. 2006;24(1):93-106. doi: 10.2165/00019053-200624010-00008. Pharmacoeconomics. 2006. PMID: 16445306
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
